QL
HAE icon

Quarry LP’s Haemonetics HAE Stock Holding History

Quarry LP’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.25K Buy
70
+37
+112% +$2.38K ﹤0.01% 1094
2026
Q1 		$1.86K Sell
33
-245
-88% -$16K ﹤0.01% 1162
2025
Q4 		$22.3K Sell
278
-98
-26% -$6.58K ﹤0.01% 972
2025
Q3 		$18.3K Buy
+376
New +$23.3K ﹤0.01% 1454
2025
Q2 		– Sell
-495
Closed -$31.5K – 1856
2025
Q1 		$31.5K Buy
495
+192
+63% +$13.1K 0.01% 976
2024
Q4 		$23.7K Buy
+303
New +$24.3K ﹤0.01% 1089
2024
Q3 		– Sell
-471
Closed -$39K – 1816
2024
Q2 		$39K Buy
+471
New +$41.4K 0.01% 788
2024
Q1 		– Sell
-32
Closed -$2.74K – 1749
2023
Q4 		$2.74K Sell
32
-125
-80% -$10.8K ﹤0.01% 1314
2023
Q3 		$14.1K Sell
157
-427
-73% -$38.1K ﹤0.01% 805
2023
Q2 		$49.7K Buy
584
+423
+263% +$35.8K 0.02% 238
2023
Q1 		$13.3K Sell
161
-67
-29% -$5.42K ﹤0.01% 771
2022
Q4 		$17.9K Buy
+228
New +$18.3K ﹤0.01% 406

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quarry LP's HAE Position: Q2 2026 in Review

Quarry LP increased its Haemonetics (HAE) stake by 112% in Q2 2026, buying an estimated $2.38K and bringing the position to 70 shares worth $5.25K. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

Quarry LP first reported a position in HAE in Q4 2022 and has held it in 12 quarters since. The position peaked at $49.7K in Q2 2023. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Quarry LP held 70 shares of Haemonetics worth $5.25K as of Q2 2026.
  • Quarry LP bought 37 Haemonetics shares in Q2 2026, an estimated $2.38K.
  • Haemonetics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1094 holding.
  • Quarry LP first reported a position in Haemonetics in Q4 2022 and has held it in 12 quarters since.
  • Quarry LP's Haemonetics position peaked at $49.7K in Q2 2023.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.